ContractClinical Trial Agreement • February 24th, 2022
Contract Type FiledFebruary 24th, 2022CLINICAL TRIAL AGREEMENT This CLINICAL TRIAL AGREEMENT (the“Agreement”) is effective on the day of the publishing in accordance with the Act no. 340/2015 Coll. On the Register of Contracts (the “Effective Date”), by and between Fakultní nemocnice Olomouc located at I.P. Pavlova 185/6, 779 00 Olomouc, Czech Republic, represented by Prof. MUDr. Roman Havlík, Ph.D., director, IČ (Company ID): 00098892 (the “Institution”), ALX Oncology Inc., located at 866 Malcolm Road, Suite 100, Burlingame, CA 94010, USA, Company ID no.: 47-2849014 (the “Sponsor”), prof. MUDr. Bohuslav Melichar, PhD., an employee of the Institution, shall serve as the principal investigator (“Investigator”) for the Study as defined below. The Institution and the Investigator may be collectively referred to as the “Site”. Pharmaceutical Research Associates CZ, s.r.o., located at Prague 7 Jankovcova 1569/2c Postal Code 170 00 Czech Republic (“PRA”) is serving as Sponsor’s contract research organization for the Study, but n